| Year |
Citation |
Score |
| 2019 |
Cato L, de Tribolet-Hardy J, Lee I, Rottenberg JT, Coleman I, Melchers D, Houtman R, Xiao T, Li W, Uo T, Sun S, Kuznik NC, Göppert B, Ozgun F, van Royen ME, ... ... Groner AC, et al. ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer. Cancer Cell. PMID 30773341 DOI: 10.1016/J.Ccell.2019.01.008 |
0.754 |
|
| 2017 |
Groner AC, Brown M. Role of steroid receptor and coregulator mutations in hormone-dependent cancers. The Journal of Clinical Investigation. 127: 1126-1135. PMID 28368289 DOI: 10.1172/Jci88885 |
0.677 |
|
| 2017 |
Dreijerink KM, Groner AC, Vos ES, Font-Tello A, Gu L, Chi D, Reyes J, Cook J, Lim E, Lin CY, de Laat W, Rao PK, Long HW, Brown M. Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer. Cell Reports. 18: 2359-2372. PMID 28273452 DOI: 10.1016/J.Celrep.2017.02.025 |
0.692 |
|
| 2016 |
Groner AC, Brown M, Theurillat JP. Targeting Transcriptional Co-Activators in Advanced Prostate Cancer. Cell Cycle (Georgetown, Tex.). 0. PMID 27610751 DOI: 10.1080/15384101.2016.1229019 |
0.738 |
|
| 2016 |
Spangle JM, Dreijerink KM, Groner AC, Cheng H, Ohlson CE, Reyes J, Lin CY, Bradner J, Zhao JJ, Roberts TM, Brown M. PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer. Cell Reports. PMID 27292631 DOI: 10.1016/J.Celrep.2016.05.046 |
0.556 |
|
| 2016 |
Groner AC, Cato L, de Tribolet-Hardy J, Bernasocchi T, Janouskova H, Melchers D, Houtman R, Cato AC, Tschopp P, Gu L, Corsinotti A, Zhong Q, Fankhauser C, Fritz C, Poyet C, et al. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer. Cancer Cell. PMID 27238081 DOI: 10.1016/J.Ccell.2016.04.012 |
0.757 |
|
| 2016 |
Groner AC, Cato L, Tribolet-Hardy Jd, Bernasocchi T, Zhong Q, Fankhauser C, Fritz C, Poyet C, Wagner U, Garraway LA, Wild PJ, Theurillat J, Brown M. Abstract 1806: TRIM24 is an oncogenic transcriptional activator in prostate cancer Cancer Research. 76: 1806-1806. DOI: 10.1158/1538-7445.Am2016-1806 |
0.768 |
|
| 2015 |
Groner AC, Tribolet-Hardy Jd, Theurillat J, Wild PJ, Brown M. Abstract 1865: TRIM24 acts as a transcriptional co-activator of the androgen receptor during prostate cancer progression Endocrinology. 75: 1865-1865. DOI: 10.1158/1538-7445.Am2015-1865 |
0.742 |
|
| 2014 |
Theurillat JP, Udeshi ND, Errington WJ, Svinkina T, Baca SC, Pop M, Wild PJ, Blattner M, Groner AC, Rubin MA, Moch H, Prive GG, Carr SA, Garraway LA. Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer. Science (New York, N.Y.). 346: 85-89. PMID 25278611 DOI: 10.1126/Science.1250255 |
0.602 |
|
| 2013 |
Texari L, Dieppois G, Vinciguerra P, Contreras MP, Groner A, Letourneau A, Stutz F. The nuclear pore regulates GAL1 gene transcription by controlling the localization of the SUMO protease Ulp1. Molecular Cell. 51: 807-18. PMID 24074957 DOI: 10.1016/J.Molcel.2013.08.047 |
0.31 |
|
| 2013 |
Groner AC, Brown M. The role of TRIM24 during prostate cancer progression Epigenetics & Chromatin. 6. DOI: 10.1186/1756-8935-6-S1-P24 |
0.716 |
|
| 2013 |
Xu K, Wu ZJ, Groner AC, He HH, Cai C, Stack EC, Loda M, Liu T, Morrissey C, Vessella RL, Kantoff PW, Balk SP, Liu XS, Brown M. Polycomb-independent activity of EZH2 in castration resistant prostate cancer Epigenetics & Chromatin. 6. DOI: 10.1186/1756-8935-6-S1-O14 |
0.753 |
|
| 2012 |
Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, Xu H, Cato L, Thornton JE, Gregory RI, Morrissey C, et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science (New York, N.Y.). 338: 1465-9. PMID 23239736 DOI: 10.1126/Science.1227604 |
0.757 |
|
| Show low-probability matches. |